Skip to main content

Table 1 Baseline characteristics of the participants in the intervention (ZemCAD) and control (CAU) groups (n = 141)

From: Effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders on quality of life, symptoms, and empowerment: results of a randomized controlled trial

  ZemCAD (n = 70) Control (n = 71)
Gender, n (%)
 Female 46 (65.70) 47 (66.20)
 Male 24 (34.30) 24 (33.80)
Age (years)
 Mean (SD) 47.03 (7.68) 47.87 (8.90)
 Range 28–63 27–63
Education, n (%)
 Low 34 (50.00) 38 (53.50)
 Intermediate 12 (17.60) 16 (22.50)
 High 22 (32.40) 17 (23.90)
Employment, n (%)
 Paid 14 (20.60) 13 (18.30)
 No paid 54 (79.40) 58 (81.70)
Nationality, n (%)
 Dutch 59 (84.30) 59 (83.10)
 Other 11 (15.70) 12 (16.90)
Partner status, n (%)
 Single 26 (37.10) 39 (54.90)
 Living with partner 44 (62.90) 32 (45.10)
Age of first onset, M (SD) 27.57 (12.22) 24.97 (14.07)
Duration of current symptoms (years), M (SD) 3.59 (5.90) 5.99 (8.06)
Diagnosis according to MINIa, n (%)
 Anxiety 12 (17.10) 12 (16.90)
 Depression 16 (22.90) 21 (29.60)
 Both anxiety and depression 29 (41.40) 33 (46.50)
 No current anxiety or depression 13 (18.60) 5 (7.00)
Quality of life (WHOQOL-BREFb), M (SD) 73.49 (15.34) 72.03 (13.11)
Anxiety (BAIc), M (SD) 43.82 (13.57) 45.28 (11.27)
Depression (PHQ-9d), M (SD) 22.51 (6.42) 23.18 (6.58)
Empowerment (NELe), M (SD) 121.88 (20.46) 121.48 (16.57)
  1. aMINI = MINI International Neuropsychiatric Interview
  2. bWHOQOL-BREF World Health Organisation Quality of Life, Brief version
  3. cBAI Beck Anxiety Inventory
  4. dPHQ-9 Patient Health Questionnaire
  5. eNEL Netherlands Empowerment List